Current gene sequencing and molecular diagnostic methods often lack the throughput and speed required for rapid analysis and real-time results, hindering timely decision-making in healthcare and research settings. Existing technologies may also be limited in their ability to perform single-molecule analysis, affecting accuracy and sensitivity.

Axbio is developing a Bio-CMOS platform that leverages nanopore sequencing technology for high-throughput gene sequencing and molecular diagnostics. Their platform enables real-time, single-molecule analysis, providing rapid and accurate genomic data. The core of the technology is a Bio-CMOS chip with a high density of nanopores, which facilitates high-throughput sequencing at a lower cost. Axbio's solutions aim to improve diagnostic capabilities and accelerate research by providing faster and more precise genomic information.

High-throughput sequencing using a Bio-CMOS platform

Nanopore sequencing technology for real-time, single-molecule analysis

Bio-CMOS chip with a high density of nanopores for increased throughput

Technology uses a "nanopore sequencing by synthesis" approach, incorporating polymerase and labeled modified nucleotides for base identification and physical correction through single-molecule cyclic re-sequencing

Electrochemical impedance detection technology for smaller, denser, more stable, and higher-throughput detection units compared to DC electrical signals

Specializes in developing fourth-generation gene sequencing platforms, nucleic acid joint testing platforms, and corresponding reagent kit products

The primary target audience includes healthcare providers, research institutions, and diagnostic companies seeking advanced solutions for rapid and accurate gene sequencing and molecular diagnostics.